Abstract
The MIR137 locus is a replicated genetic risk factor for schizophrenia. The risk-associated allele is reported to increase miR- 137 expression and miR-137 overexpression alters synaptic transmission in mouse hippocampus. We investigated the cellular mechanisms underlying these observed effects in mouse hippocampal neurons in culture. First, we correlated the risk allele to expression of the genes in the MIR137 locus in human postmortem brain. Some evidence for increased MIR137HG expression was observed, especially in hippocampus of the disease-associated genotype. Second, in mouse hippocampal neurons, we confirmed previously observed changes in synaptic transmission upon miR-137 overexpression. Evoked synaptic transmission and spontaneous release were 50% reduced. We identified defects in release probability as the underlying cause. In contrast to previous observations, no evidence was obtained for selective synaptic vesicle docking defects. Instead, ultrastructural morphometry revealed multiple effects of miR-137 overexpression on docking, active zone length and total vesicle number. Moreover, proteomic analyses of neuronal protein showed that expression of Syt1 and Cplx1, previously reported as downregulated upon miR-137 overexpression, was unaltered. Immunocytochemistry of synapses overexpressing miR-137 showed normal Synaptotagmin1 and Complexin1 protein levels. Instead, our proteomic analyses revealed altered expression of genes involved in synaptogenesis. Concomitantly, synaptogenesis assays revealed 31% reduction in synapse formation. Taken together, these data show that miR-137 regulates synaptic function by regulating synaptogenesis, synaptic ultrastructure and synapse function. These effects are plausible contributors to the increased schizophrenia risk associated with miR-137 overexpression.
| Original language | English |
|---|---|
| Pages (from-to) | 1879-1891 |
| Number of pages | 13 |
| Journal | Human Molecular Genetics |
| Volume | 27 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 1 Jun 2018 |
Funding
The authors thank Sara Grasman for immunocytochemical experiments and morphometry and Rien Dekker for the electron microscopy. We also thank Dr Ronald E. van Kesteren and Dr Pim van Nierop for discussion of the project. We thank Rob Zwart and Marieke van Ziel for their help on qPCR experiment. This work was supported by the Swedish Research Council (VR Dnr: 538-2013-8865 to P.F.S.), the European Union (ERC Advanced grant 322966 to M.V.; HEALTH-F2-2009-241498 EUROSPIN to M.V. and HEALTH-F2-2009-242167 SynSys to A.B.S. and M.V.), The Netherlands Organization for Scientific Research (NWO VICI 453-14-005 to D.P.). The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH and NINDS. The data used for the analyses described in this article were obtained fromthe GTEx Portal on February 17, 2016. Funding to pay the Open Access publication charges for this article was provided by Section of Functional Genomics, Faculty of Science, Vrije Universiteit Amsterdam. This work was supported by the Swedish Research Council (VR Dnr: 538–2013-8865 to P.F.S.), the European Union (ERC Advanced grant 322966 to M.V.; HEALTH-F2–2009-241498 EUROSPIN to M.V. and HEALTH-F2–2009-242167 SynSys to A.B.S. and M.V.), The Netherlands Organization for Scientific Research (NWO VICI 453– 14-005 to D.P.). The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH and NINDS. The data used for the analyses described in this article were obtained from the GTEx Portal on February 17, 2016. Funding to pay the Open Access publication charges for this article was provided by Section of Functional Genomics, Faculty of Science, Vrije Universiteit Amsterdam.
| Funders | Funder number |
|---|---|
| Netherlands Organization for Scientific Research | |
| National Institutes of Health | |
| National Institute of Mental Health | U01MH109528 |
| National Institute on Drug Abuse | |
| National Heart, Lung, and Blood Institute | |
| National Human Genome Research Institute | |
| National Cancer Institute | |
| National Institute of Neurological Disorders and Stroke | |
| European Commission | |
| European Research Council | 322966, HEALTH-F2–2009-242167 |
| Nederlandse Organisatie voor Wetenschappelijk Onderzoek | VICI 453– 14-005 |
| Vetenskapsrådet | 538–2013-8865 |
| National Institute of Development Administration |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'MIR137 schizophrenia-associated locus controls synaptic function by regulating synaptogenesis, synapse maturation and synaptic transmission'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver